FHD-286: Clinical Trials

1 trial of FHD-286, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 11Terminated 1

Follow FHD-286: new trials by email Literature Review of FHD-286 trials Research Report on FHD-286

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
FHD-286 in Subjects With Metastatic Uveal Melanoma
FHD-286 - Metastatic Uveal Melanoma
Phase 1TerminatedFoghorn Therapeutics Inc.762021-05-112024-04-25

Conditions studied

Uveal Melanoma (1)

Sponsors

Foghorn Therapeutics Inc. (1)

Countries

France (1)  ·  Netherlands (1)  ·  United States (1)

Top investigators

Sarah Reilly, MD (1)